Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Galli

Showing results (81-90 of 217) with videos related to

Pageof 22
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2010
Liver histology in HIV/hepatitis C-coinfected and HCV-monoinfected patients with persistently normal alanine aminotransferasesCaterina Sagnelli, Caterina Uberti-Foppa, Laura Galli, et al.
Annali Dell'Istituto Superiore Di Sanita|June 23, 2020
Stress and wellbeing among professionals working with people with neurodevelopmental disorders. Review and intervention perspectivesMauro Leoni, Laura Alzani, Davide Carnevali, et al.
The New Microbiologica|May 29, 2023
No need to modify treatment within the first month after rapid start of a tailored antiretroviral therapy: the TWODAY StudyNicola Gianotti, Laura Galli, Michela Sampaolo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 23, 2023
Viral Hepatitis and Human Papillomavirus Vaccination During HIV Pre-Exposure Prophylaxis: Factors Associated With Missed VaccinationAngelo Roberto Raccagni, Daniele Ceccarelli, Benedetta Trentacapilli, et al.
Microorganisms|June 27, 2024
Clinico-Virological Outcomes and Mutational Profile of SARS-CoV-2 in Adults Treated with Ribavirin Aerosol for COVID-19 PneumoniaGiulia Morsica, Emanuela Messina, Sabrina Bagaglio, et al.
Antiviral Therapy|April 29, 2022
Rilpivirine plus cobicistat-boosted darunavir as alternative to standard three-drug therapy in HIV-infected, virologically suppressed subjects: Final results of the PROBE 2 trialFranco Maggiolo, Nicola Gianotti, Laura Comi, et al.
The Annals of Thoracic Surgery|February 21, 2006
Phosphorylcholine coating may limit thrombin formation during high-risk cardiac surgery: a randomized controlled trialFederico Pappalardo, Patrizia Della Valle, Giuseppe Crescenzi, et al.
Annali Dell'Istituto Superiore Di Sanita|June 23, 2020
Neurodevelopmental disorders and development of project of lifein a lifespan perspective: between habilitation and quality of lifeRoberto Cavagnola, Laura Alzani, Davide Carnevali, et al.
AIDS (London, England)|May 16, 2021
Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patientsClaudia Pastori, Laura Galli, Gabriel Siracusano, et al.
Internal and Emergency Medicine|February 11, 2016
The Tuscan Mobile Simulation Program: a description of a program for the delivery of in situ simulation trainingEdward Ullman, Maura Kennedy, Francesco Dojmi Di Delupis, et al.
Pageof 22

Showing results (81-90 of 217) with videos related to

Sort By:
Pageof 22
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2010
Liver histology in HIV/hepatitis C-coinfected and HCV-monoinfected patients with persistently normal alanine aminotransferasesCaterina Sagnelli, Caterina Uberti-Foppa, Laura Galli, et al.
Annali Dell'Istituto Superiore Di Sanita|June 23, 2020
Stress and wellbeing among professionals working with people with neurodevelopmental disorders. Review and intervention perspectivesMauro Leoni, Laura Alzani, Davide Carnevali, et al.
The New Microbiologica|May 29, 2023
No need to modify treatment within the first month after rapid start of a tailored antiretroviral therapy: the TWODAY StudyNicola Gianotti, Laura Galli, Michela Sampaolo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 23, 2023
Viral Hepatitis and Human Papillomavirus Vaccination During HIV Pre-Exposure Prophylaxis: Factors Associated With Missed VaccinationAngelo Roberto Raccagni, Daniele Ceccarelli, Benedetta Trentacapilli, et al.
Microorganisms|June 27, 2024
Clinico-Virological Outcomes and Mutational Profile of SARS-CoV-2 in Adults Treated with Ribavirin Aerosol for COVID-19 PneumoniaGiulia Morsica, Emanuela Messina, Sabrina Bagaglio, et al.
Antiviral Therapy|April 29, 2022
Rilpivirine plus cobicistat-boosted darunavir as alternative to standard three-drug therapy in HIV-infected, virologically suppressed subjects: Final results of the PROBE 2 trialFranco Maggiolo, Nicola Gianotti, Laura Comi, et al.
The Annals of Thoracic Surgery|February 21, 2006
Phosphorylcholine coating may limit thrombin formation during high-risk cardiac surgery: a randomized controlled trialFederico Pappalardo, Patrizia Della Valle, Giuseppe Crescenzi, et al.
Annali Dell'Istituto Superiore Di Sanita|June 23, 2020
Neurodevelopmental disorders and development of project of lifein a lifespan perspective: between habilitation and quality of lifeRoberto Cavagnola, Laura Alzani, Davide Carnevali, et al.
AIDS (London, England)|May 16, 2021
Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patientsClaudia Pastori, Laura Galli, Gabriel Siracusano, et al.
Internal and Emergency Medicine|February 11, 2016
The Tuscan Mobile Simulation Program: a description of a program for the delivery of in situ simulation trainingEdward Ullman, Maura Kennedy, Francesco Dojmi Di Delupis, et al.
Pageof 22